• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Teleflex Incorporated

    6/26/26 3:52:04 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care
    Get the next $TFX alert in real time by email
    tfx-20260626
    FALSEFALSE00000969430000096943iso4217:USDxbrli:puretfx:loanxbrli:shares0000096943tfx:EBP010Member2025-01-012025-12-3100000969432025-01-012025-12-310000096943tfx:EBP010Member2025-12-310000096943tfx:EBP010Member2024-12-310000096943tfx:EBP010Memberus-gaap:MutualFundMember2025-12-310000096943tfx:EBP010Memberus-gaap:MutualFundMember2024-12-310000096943tfx:EBP010Memberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMember2025-12-310000096943tfx:EBP010Memberus-gaap:DefinedBenefitPlanCommonCollectiveTrustMember2024-12-310000096943tfx:EBP010Memberus-gaap:CommonStockMember2025-12-310000096943tfx:EBP010Memberus-gaap:CommonStockMember2024-12-310000096943tfx:EBP010Member2024-01-012024-12-310000096943tfx:EBP010Member2023-12-310000096943tfx:EBP010Membersrt:MinimumMember2025-01-012025-12-310000096943tfx:EBP010Membersrt:MaximumMember2025-01-012025-12-310000096943tfx:EBP010Memberus-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember2025-12-310000096943tfx:EBP010Memberus-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember2024-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2025-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2025-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2025-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2025-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2025-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2025-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000096943us-gaap:DefinedBenefitPlanCommonCollectiveTrustMembertfx:EBP010Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2024-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2024-12-310000096943us-gaap:MutualFundMembertfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2024-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2024-12-310000096943us-gaap:CommonStockMembertfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel1Member2024-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel2Member2024-12-310000096943tfx:EBP010Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000096943us-gaap:DefinedBenefitPlanCommonCollectiveTrustMembertfx:EBP010Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-12-310000096943tfx:EBP010MemberAmerican Funds New Perspective Fund; Class R-6 | Registered Investment Company2025-12-310000096943tfx:EBP010MemberAmerican Funds New World Fund; Class R6 | Registered Investment Company2025-12-310000096943tfx:EBP010MemberColumbia Dividend Income: Institutional Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberJPMorgan Small Cap Equity Fund; Class R6 | Registered Investment Company2025-12-310000096943tfx:EBP010MemberJPMorgan Large Cap Growth Fund; Class R6 | Registered Investment Company2025-12-310000096943tfx:EBP010MemberMetropolitan West Total Return Bond Fund; P Class | Registered Investment Company2025-12-310000096943tfx:EBP010MemberTouchstone Midcap R6 | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Explorer Fund: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Extended Market Index Fund: Institutional Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Federal Money Market Fund | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Inflation-Protected Securities Fund: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Institutional Index Fund | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard International Growth: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Real Estate Index: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Small-Cap Index Fund: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Total Bond Market Index Fund Institutional Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Total International Stock Index Fund Institutional Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Total World Stock Index Fund: Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberFidelity Large Cap Growth Index | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVanguard Wellington Fund Admiral Shares | Registered Investment Company2025-12-310000096943tfx:EBP010MemberVictory Core Plus Intermediate Bond | Registered Investment Company2025-12-310000096943tfx:EBP010MemberTeleflex Stock Fund | Unitized Stock Fund2025-12-310000096943tfx:EBP010MemberVanguard Retirement Savings Trust III | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2020 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2025 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2030 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2035 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2040 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2045 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2050 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2055 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2060 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2065 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Target Retirement 2070 II | Common Collective Trust Fund2025-12-310000096943tfx:EBP010MemberVanguard Retirement Income Trust II | Common Collective Trust Fund2025-12-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 11-K
    (Mark One)
    x    ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2025
    OR
    o    TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from _________________________________ to ______________________________
    Commission File Number: 001-05353
    ____________________
    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:
    Teleflex 401(k) Savings Plan
    B.Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
    Teleflex Incorporated
    550 East Swedesford Road, Suite 400
    Wayne, Pennsylvania 19087



    TELEFLEX 401(k) SAVINGS PLAN
    AUDITED FINANCIAL STATEMENTS AND SCHEDULE
    Years Ended December 31, 2025 and 2024
    TABLE OF CONTENTS
    Page No.
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM2
    AUDITED FINANCIAL STATEMENTS
    Statements of Net Assets Available for Benefits3
    Statements of Changes in Net Assets Available for Benefits4
    Notes to Financial Statements5
    SUPPLEMENTAL SCHEDULE
    Schedule H, Line 4i - Schedule of Assets (Held at End of Year)11
    SIGNATURE12
    INDEX TO EXHIBITS
    13
    -1-


    Report of Independent Registered Public Accounting Firm
    Plan Administrator and Participants
    Teleflex 401(k) Savings Plan
    Wayne, Pennsylvania
    Opinion on the Financial Statements
    We have audited the accompanying statements of net assets available for benefits of the Teleflex 401(k) Savings Plan (the “Plan”) for the years ended December 31, 2025 and 2024, the related statements of changes in net assets available for benefits for the years then ended, and the related notes (collectively, the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the years then ended, in conformity with accounting principles generally accepted in the United States of America.
    Basis for Opinion
    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
    Our audits included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by the Plan’s management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    Supplemental Information
    The supplemental information in the accompanying ERISA-required Supplemental Schedule H, line 4i- Schedule of Assets (Held at End of Year) as of December 31, 2025 has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is presented for the purpose of additional analysis and is not a required part of the financial statements but included supplemental information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.
    /s/ BDO USA, P.C.
    We have served as the Plan’s auditor since 2024.
    Philadelphia, Pennsylvania
    June 26, 2026
    -2-

    TELEFLEX 401(k) SAVINGS PLAN
    STATEMENTS OF NET ASSETS
    AVAILABLE FOR BENEFITS
    December 31, 2025 and 2024

    20252024
    Assets
    Cash and cash equivalents$— $8,622 
    Investments, at fair value
    Registered investment companies350,602,752 322,899,889 
    Common collective trusts385,638,305 334,344,077 
    Common stock fund21,634,975 33,639,899 
    Total investments, at fair value757,876,032 690,883,865 
    Receivables
    Participant loans receivable8,131,154 8,101,350 
    Net assets
    Available for benefits$766,007,186 $698,993,837 
    See accompanying notes
    -3-

    TELEFLEX 401(k) SAVINGS PLAN
    STATEMENTS OF CHANGES IN NET ASSETS
    AVAILABLE FOR BENEFITS
    For the years ended December 31, 2025 and 2024

    20252024
    Additions to net assets
    Contributions
    Employer
    $6,812,066 $17,908,894 
    Employee
    34,783,588 34,663,703 
    Rollover
    7,127,778 10,435,822 
    Total contributions
    48,723,432 63,008,419 
    Investment income
    Interest and dividends
    18,612,286 13,167,629 
    Net appreciation in fair value of investments
    73,244,672 50,480,676 
    Total investment income
    91,856,958 63,648,305 
    Interest Income on participant loans
    704,277 603,438 
    Total additions
    141,284,667 127,260,162 
    Deductions from net assets
    Benefits paid to participants
    73,796,951 86,102,079 
    Administrative fees
    463,730 527,278 
    Other deductions
    10,637 — 
    Total deductions
    74,271,318 86,629,357 
    Net increase
    67,013,349 40,630,805 
    Plan assets transferred in (Note G)— 42,983,680 
    Net assets available for benefits
    Beginning of year
    698,993,837 615,379,352 
    End of year
    $766,007,186 $698,993,837 
    See accompanying notes
    -4-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2025 and 2024
    Note A — General description of the plan and summary of significant accounting policies
    General Description of the Plan
    A general description of the Teleflex 401(k) Savings Plan (the “Plan”) follows. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
    General - The Plan is a defined contribution plan, which was implemented effective July 1, 1985. Certain employees of Teleflex Incorporated (the “Company”) or one of its related entities that is a participating employer in the Plan who have attained age 21 are eligible to participate in the Plan. Full-time and part-time employees are eligible to enter the Plan at their date of hire. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended ("ERISA").
    The Plan includes an employee stock ownership plan ("ESOP") feature, as defined in Section 4975(e)(7) of the Internal Revenue Code of 1986, as amended ( the "Code"). The ESOP feature permits a participant to elect to have any dividend paid on the shares of Company common stock allocated to his or her account either paid in cash or deposited into his or her account in the ESOP portion of the Plan and reinvested in the Company common stock fund.
    Safe Harbor Plan/Automatic Contributions - The Plan is intended to satisfy the requirements to be a “qualified automatic contribution arrangement” ("QACA") with the meaning of Code Sections 401(k)(13) and 401(m)(12), as well as an “eligible automatic contribution arrangement” ("EACA") within the meaning of Code Section 414(w). The EACA permits a penalty-free distribution of “accidental” automatic deferrals made to the Plan within 90 days of the effective date of a participant’s first automatic contribution. The QACA is a safe harbor plan design that allows the Plan to automatically satisfy annual nondiscrimination tests (the actual deferral percentage test and the actual contribution percentage ("ACP") test).
    Under the safe harbor design, once a participant becomes eligible to participate in the Plan, the participant is automatically enrolled at a 3% deferral rate unless opting out of the automatic deferral feature. Thereafter, the automatic deferral percentage increases by 1% each year up to a maximum automatic deferral of 10%. As part of the QACA, the Company makes “Safe Harbor Non-Elective Contributions” in an amount equal to 3% of each participant’s compensation paid during the portion of the year in which he or she is a participant.
    Contributions - Participants were able to contribute up to the lesser of $23,500 and $23,000 or 50% of their annual compensation during 2025 and 2024, respectively. These contributions are referred to as “elective deferral contributions” and are withheld from participant’s pay on a pre-tax basis for federal income tax and most state income tax purposes. However, participants may designate all or part of their elective deferral contributions as “Roth elective deferral contributions.” Roth elective deferral contributions are made on an after-tax basis for federal income tax purposes.
    In addition, participants who reach age 50 or older and contribute the maximum permitted under the Plan may make an additional pre-tax contribution (a “catch-up contribution”) of up to $7,500 during 2025 and 2024, respectively. As with regular elective deferral contributions, participants may elect to designate all or part of their catch-up contributions as after-tax “Roth catch-up contributions.” Participants may also contribute amounts representing distributions from other qualified benefit plans (via a rollover contribution into the Plan). As stated above, the Company makes employer Safe Harbor Non-Elective Contributions equal to 3% of a participant’s compensation paid during the portion of the year in which he or she is a participant. For the year ending December 31, 2025, the Company also made “Non-Safe Harbor Matching Contributions" equal to 100% of elective deferral contributions (including Roth elective deferral contributions and catch-up contributions) up to 2% of compensation that are designed to automatically satisfy the ACP test. For purposes of calculating contributions, compensation is limited to a maximum of $350,000 and $345,000 during 2025 and 2024, respectively.
    Participant Accounts - Each participant’s account is credited with the participant’s contribution and the employer contributions, as well as an allocation of Plan earnings. Participants may access their accounts via a website and toll-free telephone number. Fund transfers and investment election changes may be elected daily or once in a 30-day timeframe depending on the fund type. A participant may stop, start, or change their 401(k) salary deferral rate at will.
    -5-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2025 and 2024
    Plan Loans - Active employees may elect to take up to two loans from the Plan at any given time. As required by law, a loan amount is limited to the lesser of $50,000 or 50% of the participant’s vested account and must be repaid within five years unless the loan is for the purchase of a primary residence. The loans are secured by the balance in the participant's account and bear a fixed interest rate over the term of the loan. The interest rate is established on the date the loan is granted at prime rate plus 2%. Loan repayments are processed via payroll deduction on an after-tax basis. The entire unpaid balance on any outstanding loan and all interest due thereon will be processed as a taxable distribution and will reduce the participant’s distributable account balance if any of the following occur: (i) a participant fails to make an installment payment due under the loan by the last day of the calendar quarter following the calendar quarter in which the required installment payment was due; (ii) a participant on a leave of absence has an unpaid amount for a period of a year; or (iii) a participant incurs a severance from employment.
    Vesting - Participants are always 100% vested in their own 401(k) elective deferral contributions. With the exception of certain discretionary employer contributions and matching contributions (if any) that become 100% vested after participants have completed three years of employment, the Company’s contributions, including Safe Harbor Non-Elective Contributions, Safe Harbor Matching Contributions made prior to January 1, 2025, discretionary profit sharing contributions made for years beginning on and after January 1, 2024, and Non-Safe Harbor Matching Contributions made for years beginning on and after January 1, 2025, become 100% vested after participants have completed two years of employment.
    Payment of Benefits - Benefits are recorded when paid. The Plan provides that a participant may elect to withdraw 100% of his or her vested account balance at the termination of employment. A participant who is an employee and has attained age 59½ may elect to withdraw any portion of his or her non-forfeitable account in accordance with the procedures established by the Plan Administrator. Withdrawals shall be made on a pro-rata basis if a Participant elects to make a withdrawal from more than one sub-account in his or her account. In addition, a participant may elect a hardship withdrawal, as defined by the Plan, of his or her elective deferral contributions, Roth elective deferral contributions, catch-up contributions and Roth catch-up contributions. A participant may elect to withdraw his or her rollover account at any time. Mandatory distributions are made in accordance with Plan provisions.
    Forfeitures - Forfeitures of terminated participants’ nonvested accounts are used to reduce the amount of contributions made to the Plan by the Company and the other participating employers in the Plan if the Company and participating employers do not elect to fund the entire amount of such contributions out of their assets and to the extent such contributions are not funded with assets from the qualified replacement plan suspense account described in Note G. In addition, for any year, to the extent that such forfeitures are not used to reduce the Company’s or other participating employers’ contributions to the Plan, the Plan Administrator may allocate and use forfeitures to pay Plan expenses. The amount of unallocated forfeitures at December 31, 2025 and 2024 were $866,855 and $322,983, respectively. For the year ended December 31, 2025 and 2024, forfeitures used to offset employer contributions were $1,100,115 and $799,834, respectively.
    Plan Termination - Although it has not expressed any intent to do so, the Company has the right to discontinue its contributions at any time and to terminate the Plan at any time, subject to the provisions set forth in ERISA. In the event of Plan termination, distribution of participant accounts shall be in accordance with ERISA and its applicable regulations and Article XIII of the Plan document.
    Plan Amendments - An amendment to the Plan was executed on December 18, 2025, which allows all employees from the Vascular Intervention business of BIOTRONIK SE & Co. KG ("Biotronik"), which was acquired on June 30, 2025, to participate in the Plan beginning on July 1, 2025. The amendment granted an individual who was a Biotronik employee immediately prior to July 1, 2025 full credit for purposes of eligibility and vesting under the Plan for the individual’s most recent continuous period of service with Biotronik. All former Biotronik employees who were eligible to participate in the Plan were provided an option to rollover their Biotronik/Micro Systems Engineering 401(k) Plan account balances into the Plan.

    Investments - Participants direct the investment of their contributions into various investment options offered by the Plan. The Plan currently offers several mutual funds, common collective trusts, as well as the Company common stock fund as investment options for participants.
    -6-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2025 and 2024
    Significant Accounting Policies
    The significant accounting policies of the Plan employed in the preparation of the accompanying financial statements follow:
    Valuation of investments - The Plan’s investments are stated at fair value pursuant to the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) No. 820, Fair Value Measurements and Disclosures. Fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note E for further information on fair value measurements.
    Participant Loans Receivable - All transactions are measured at their unpaid principal balance plus any accrued but unpaid interest. Any individual credit risk related to participant loans is mitigated by the fact that these loans are secured by the participant’s vested balance. If a participant were to default, the participant’s account balance would be offset by the unpaid balance of the loan, and the participant would be subject to tax on the unpaid loan balance. As such, the participant is the only party affected in the event of a default.
    Revenue Recognition and Method of Accounting - All transactions are recorded on an accrual basis. Purchases and sales of investments are recorded on a trade-date basis. Interest income is accrued when earned. Dividend income is recorded on the ex-dividend date. Capital gain distributions are included in dividend income. Net appreciation (depreciation) includes the gains and losses on investments bought and sold as well as held during the year. Expenses are recorded as incurred.
    Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts of assets, liabilities and changes therein and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.
    Note B — Administration of the plan
    The Plan is administered by a committee of at least three members appointed by the Company’s Board of Directors. The committee is the Plan Administrator and fiduciary for ERISA purposes. Charles Schwab Bank ("Schwab") is the trustee and third-party administrator of the Plan. Schwab charges a per participant fee for the administrative services that it provides to the Plan. Actively employed participants pay a small portion of the participant fee on a quarterly basis. The Company and any other Company affiliate that participates in the Plan (a "Participating Employer") pay the remaining portion of the fee for participants who are actively employed by the Company or a Participating Employer. Participants who are not actively employed by the Company or a Participating Employer pay the per participant administrative fee from their Plan accounts. Investment management fees charged by each mutual fund are netted against returns. Investment management fees charged by the common collective trust funds are charged to participants with balances in the respective trust.
    Note C — Tax status of the plan
    The Plan obtained its latest determination letter on August 4, 2015, in which the Internal Revenue Service indicated that the Plan, as then designed, was in compliance with the applicable requirements of the Code (i.e., satisfied the applicable requirements of Code Section 401 et. seq. to be a tax-qualified plan and satisfied the applicable requirements of Code Section 501 et. seq. for the Plan’s trust to be a tax-exempt trust). Although the Plan has been amended since receiving the determination letter, the Plan Administrator and the Plan’s legal counsel believe that the Plan as currently designed, continues to satisfy the applicable requirements of Code Sections 401 and 501 et. seq. to be a tax-qualified plan and tax-exempt trust. In addition, to the knowledge of the Plan Administrator and the Plan’s legal counsel, the Plan and its trust are currently being operated in compliance with the applicable requirements of Code Sections 401 and 501 et. seq. and, therefore, the Plan and its related trust are tax-qualified and tax-exempt, respectively.
    Accounting principles generally accepted in the United States of America require the Plan’s management to evaluate tax positions taken by the Plan and recognize a tax liability or asset if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. The Plan Administrator has analyzed the tax positions by the Plan and has concluded that as of December 31, 2025 and
    -7-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2025 and 2024
    2024, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or asset or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
    Note D — Related party transactions and party in interest transactions
    The Plan participants invest in shares of the Company’s stock through the Teleflex Incorporated common stock fund. The common stock fund held 176,658 and 187,903 shares of the Teleflex Incorporated common stock representing 3% and 5% of Plan assets as of December 31, 2025 and 2024, respectively. These transactions, in addition to participant loan receivables, qualify as party-in-interest transactions and are exempt from the prohibited transaction rules.
    Certain administrative functions of the Plan are performed by officers or employees of the Company. No such officer or employee received compensation from the Plan.
    Note E — Fair value measurements
    FASB ASC 820 establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under FASB ASC 820 are described as follows:
    Level 1 - inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.
    Level 2 - inputs to the fair value measurement that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
    Level 3 - inputs to the fair value measurement that are unobservable inputs for the asset or liability.
    The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
    A summary by level within the fair value hierarchy (as defined above) of the Plan’s investments measured at fair value on a recurring basis is as follows:
    Level 1Level 2December 31, 2025
    Registered investment companies$350,602,752 $— $350,602,752 
    Company common stock fund— 21,634,975 21,634,975 
    Total investments in fair value hierarchy
    350,602,752 21,634,975 372,237,727 
    Common collective trusts measured at net asset value (1)
    — — 385,638,305 
    Total investments, at fair value
    $350,602,752 $21,634,975 $757,876,032 
    -8-

    TELEFLEX 401(k) SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
    December 31, 2025 and 2024
    Level 1Level 2December 31, 2024
    Registered investment companies$322,899,889 $— $322,899,889 
    Company common stock fund— 33,639,899 33,639,899 
    Total investments in fair value hierarchy
    322,899,889 33,639,899 356,539,788 
    Common collective trusts measured at net asset value (1)
    — — 334,344,077 
    Total investments, at fair value
    $322,899,889 $33,639,899 $690,883,865 
    (1)    The common collective trusts are measured at the net asset value of units held at December 31, 2025 and December 31, 2024. In accordance with ASC 820, certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in the above totals are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets available for benefits. Redemptions for common collective trusts are allowed daily without any restrictions or notice periods, and there are no unfunded commitments.
    The following is a description of the valuation methodologies used for assets measured in fair value hierarchy:
    •Registered investment companies are valued at quoted market prices, which represent the net asset value of shares held by the Plan at year end. The funds are deemed to be actively traded.
    •The Company common stock fund is valued at the combined market value of the underlying stock based upon the closing price of the stock on its primary exchange times the number of shares held and the short-term cash component at year end.
    Note F — Risks and uncertainties
    Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and such changes could materially affect participants’ account balances and the amounts reported in the statement of net assets available for benefits.
    Note G — Plan Assets Transferred In
    During 2024, following the Company's decision to terminate the TRIP, a U.S. defined benefit pension plan, the Company settled all remaining benefits. As the assets within the TRIP Trust exceeded the obligations after settlement, the Company elected to transfer $42,983,680 in surplus assets to a suspense account within the Plan. A portion of the transferred assets in the qualified replacement plan suspense account must be utilized annually to comply with IRS qualified replacement plan requirements.
    For the year ended December 31, 2025, $13,345,769 of qualified replacement plan suspense account assets were utilized to fund certain employer contributions which resulted in reduced employer contributions being made from Company assets for the year ended December 31, 2025, as presented in the Plan's Statement of Changes in Net Assets Available for Benefits. For the year ended December 31, 2024, $6,253,500 of qualified replacement plan suspense account assets were utilized to fund a discretionary profit sharing contribution. The remaining balance of the qualified replacement plan suspense account is expected to be utilized for the Company's future Safe Harbor Non-Elective Contributions and/or discretionary profit sharing contributions under the Plan.

    Note H — Subsequent Events
    Plan Management has evaluated all events or transactions that occurred through June 26, 2026, the date the financial statements were issued and determined that there are no matters requiring adjustment to or disclosure in the accompanying financial statements and related notes.
    -9-














    Supplemental Schedule
    -10-

    TELEFLEX 401(k) SAVINGS PLAN
    SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
    Year Ended December 31, 2025
    Plan EIN# 23-1147939, Plan 010

    (b)(c)(e)
    (a)Identity of Issuer, Borrower, Lessor, or Similar PartyDescription of Investment, Including Maturity Date, Rate of Interest, Collateral, Par or Maturity ValueCurrent Value
    American Funds New Perspective Fund; Class R-6Registered Investment Company$3,571,269 
    American Funds New World Fund; Class R6Registered Investment Company5,891,705 
    Columbia Dividend Income: Institutional SharesRegistered Investment Company21,462,108 
    JPMorgan Small Cap Equity Fund; Class R6Registered Investment Company4,819,888 
    JPMorgan Large Cap Growth Fund; Class R6
    Registered Investment Company
    45,565,154 
    Metropolitan West Total Return Bond Fund; P ClassRegistered Investment Company15,575 
    Touchstone Midcap R6Registered Investment Company12,072,352 
    Vanguard Explorer Fund: Admiral SharesRegistered Investment Company10,852,459 
    Vanguard Extended Market Index Fund: Institutional SharesRegistered Investment Company9,502,537 
    Vanguard Federal Money Market FundRegistered Investment Company40,318,280 
    Vanguard Inflation-Protected Securities Fund: Admiral SharesRegistered Investment Company4,468,186 
    Vanguard Institutional Index FundRegistered Investment Company65,839,554 
    Vanguard International Growth: Admiral SharesRegistered Investment Company15,464,400 
    Vanguard Real Estate Index: Admiral SharesRegistered Investment Company3,338,807 
    Vanguard Small-Cap Index Fund: Admiral SharesRegistered Investment Company8,748,520 
    Vanguard Total Bond Market Index Fund Institutional SharesRegistered Investment Company17,668,050 
    Vanguard Total International Stock Index Fund Institutional SharesRegistered Investment Company23,146,283 
    Vanguard Total World Stock Index Fund: Admiral SharesRegistered Investment Company11,784,375 
    Fidelity Large Cap Growth IndexRegistered Investment Company10,405,354 
    Vanguard Wellington Fund Admiral SharesRegistered Investment Company29,474,140 
    Victory Core Plus Intermediate BondRegistered Investment Company6,193,756 
    *Teleflex Stock FundUnitized Stock Fund21,634,975 
    Vanguard Retirement Savings Trust III
    Common Collective Trust Fund
    22,167,336 
    Vanguard Target Retirement 2020 II
    Common Collective Trust Fund
    4,240,581 
    Vanguard Target Retirement 2025 II
    Common Collective Trust Fund
    23,376,516 
    Vanguard Target Retirement 2030 II
    Common Collective Trust Fund
    38,282,948 
    Vanguard Target Retirement 2035 II
    Common Collective Trust Fund
    65,003,993 
    Vanguard Target Retirement 2040 II
    Common Collective Trust Fund
    54,199,396 
    Vanguard Target Retirement 2045 II
    Common Collective Trust Fund
    58,126,874 
    Vanguard Target Retirement 2050 II
    Common Collective Trust Fund
    45,562,858 
    Vanguard Target Retirement 2055 II
    Common Collective Trust Fund
    39,658,991 
    Vanguard Target Retirement 2060 II
    Common Collective Trust Fund
    22,094,311 
    Vanguard Target Retirement 2065 II
    Common Collective Trust Fund
    6,370,282 
    Vanguard Target Retirement 2070 II
    Common Collective Trust Fund
    1,548,566 
    Vanguard Retirement Income Trust II
    Common Collective Trust Fund
    5,005,653 
    *Participant Loans
    Participant Loans at rates between 5.25% to 10.50% with various maturities through May 2055
    8,131,154 
    $766,007,186 
    *Party-in-interest.
    Cost information not required as all investments are participant-directed.
    -11-


    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
    Teleflex 401(k) Savings Plan
    By:/s/ Cameron P. Hicks
    Cameron P. Hicks
    Corporate Vice President & Chief Human Resource Officer
    Dated: June 26, 2026
    -12-


    INDEX TO EXHIBITS
    Exhibit No.Description
    23.1-
    Consent of BDO USA, P.C, Independent Registered Public Accounting Firm
    -13-
    Get the next $TFX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TFX

    DatePrice TargetRatingAnalyst
    6/8/2026$160.00Neutral → Overweight
    Piper Sandler
    5/8/2026$155.00Sector Perform → Outperform
    RBC Capital Mkts
    4/13/2026$135.00Underperform → Neutral
    BofA Securities
    3/27/2026$128.00Mkt Perform → Outperform
    Raymond James
    1/27/2026$138.00Hold → Buy
    Needham
    3/4/2025$235.00 → $140.00Neutral → Underperform
    BofA Securities
    2/28/2025$220.00 → $155.00Outperform → Sector Perform
    RBC Capital Mkts
    2/28/2025Outperform → Mkt Perform
    Raymond James
    More analyst ratings

    $TFX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Randle Stuart A bought $115,860 worth of shares (1,000 units at $115.86), increasing direct ownership by 15% to 7,547 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 6:02:01 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Director Krakauer Andrew A bought $115,250 worth of shares (1,000 units at $115.25), increasing direct ownership by 16% to 7,192 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:15:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Chairman, President & CEO Kelly Liam bought $172,605 worth of shares (1,500 units at $115.07), increasing direct ownership by 3% to 45,267 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    8/7/25 4:14:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

    Enrollment completed ahead of schedule in BIOMAG™-II Positive four-year BIOMAG™-I results recently reported Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the beginning of enrollment in the BIOMAG™‑III Study (NCT07258290), a landmark global study evaluating the Freesolve™ Resorbable Magnesium Scaffold (RMS). Dr. Itsik Ben-Dor, MedStar Health in Washington, D.C., is the first implanter in the United States (U.S.) in the IDE trial of Freesolve™ RMS. Designed as a pivotal trial to support future regulatory applications, the BIOMAG™‑III Study represents the most comprehensive planned clinical evaluation of Freesolve™ RMS to date. Cha

    6/23/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

    Persistently Low Target Lesion Failure and No New Cardiac-Related Event Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study continues to demonstrate a favorable long‑term safety profile1, with no new cardiac‑related1 events observed between two and four years follow‑up period, establishing the third-generation Freesolve™ Resorbable Magnesium Scaffold (RMS) a

    6/9/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

    Teleflex Incorporated (NYSE:TFX) ("Teleflex") announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the "Notes") at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary closing conditions. The Notes will be guaranteed by each of Teleflex's existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor under its credit agreement and certain other indebtedness. Teleflex intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 4.625% Senior Notes due 2027 (the "2027 Notes").

    6/1/26 5:40:00 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    SEC Filings

    View All

    SEC Form 11-K filed by Teleflex Incorporated

    11-K - TELEFLEX INC (0000096943) (Filer)

    6/26/26 3:52:04 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - TELEFLEX INC (0000096943) (Filer)

    6/15/26 5:24:38 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Incorporated filed SEC Form 8-K: Leadership Update

    8-K - TELEFLEX INC (0000096943) (Filer)

    6/9/26 5:13:16 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Randle Stuart A covered exercise/tax liability with 4,054 shares and was granted 5,658 shares, increasing direct ownership by 8% to 21,187 units (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    6/9/26 8:32:30 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    President and CEO Weidman Jason R. was granted 53,983 shares (SEC Form 4)

    4 - TELEFLEX INC (0000096943) (Issuer)

    6/9/26 8:31:33 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Weidman Jason R.

    3 - TELEFLEX INC (0000096943) (Issuer)

    6/9/26 8:30:44 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Teleflex upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Teleflex from Neutral to Overweight and set a new price target of $160.00

    6/8/26 8:30:04 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Teleflex from Sector Perform to Outperform and set a new price target of $155.00

    5/8/26 8:43:10 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex upgraded by BofA Securities with a new price target

    BofA Securities upgraded Teleflex from Underperform to Neutral and set a new price target of $135.00

    4/13/26 9:17:17 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Leadership Updates

    Live Leadership Updates

    View All

    Teleflex Appoints Jason Weidman as President and CEO

    Proven Industry Leader to Guide Company's Next Chapter of Growth and Value Creation Teleflex Incorporated (NYSE:TFX) today announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026. He will succeed Stuart Randle, who has been serving as Interim President and CEO since January 2026 and will continue as a member of Teleflex's Board of Directors. Mr. Weidman is expected to join the Teleflex Board when he assumes his role as President and CEO. Mr. Weidman is a proven medical technology leader with over 25 years of industry experience and a strong track record of building and scaling businesses globally. He joins Teleflex from Medtronic plc

    4/30/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces Governance Updates

    Michael J. Tokich, Medical Technology Industry Veteran, Nominated as Independent Director; Andrew A. Krakauer Appointed Chairman of the Board Effective Following 2026 Annual Meeting Board to Establish Growth and Operating Committee Company to Commence Share Repurchases Ahead of Schedule Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced several Board and governance updates, including the nomination of Michael J. Tokich to the Board of Directors, its intent to establish a new Growth and Operating Committee of the Board and its plan to commence share repurchases under the Company's previously announced program ahead of schedule. The an

    4/9/26 6:30:00 AM ET
    $MTD
    $STE
    $TFX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution

    Previously Announced Sale Transactions on Track to Close in Second Half of 2026; Expecting $1.8 Billion of Net Proceeds for Buyback and Debt Paydown Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today issued the following statement in response to the press release issued by Irenic Capital Management L.P. ("Irenic"). The Teleflex Board of Directors and management team are committed to acting in the best interests of the Company and its shareholders. Members of the Board and management team met with Irenic at their request on March 19, 2026, to better understand their views and underscore the Company's commitment to maximizing value for shareholders.

    3/27/26 12:57:00 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Financials

    Live finance-specific insights

    View All

    Teleflex Announces Quarterly Dividend

    Teleflex Incorporated (NYSE:TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 30, 2026, to shareholders of record at the close of business on May 25, 2026. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believ

    5/15/26 4:30:00 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

    Teleflex Incorporated (NYSE:TFX) (the "Company") today announced financial results for the first quarter ended March 31, 2026. First quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $548.3 million, up 32.3% compared to the prior year period, and up 5.1% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $(0.11), compared to $1.14 in the prior year period Adjusted diluted EPS from continuing operations of $1.39, compared to $1.44 in the prior year period 2026 continuing operations guidance summary1 Maintaining GAAP revenue growth guidance range of 14.40% to 15.40% Maintaining pro for

    5/7/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Teleflex Announces First Quarter 2026 Earnings Conference Call Information

    Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 7, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com. An audio replay of the call will be available beginning at 11:00 a.m. Eastern Time on May 7, 2026, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.

    4/23/26 6:30:00 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    $TFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/14/24 1:28:29 PM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    11/8/24 10:29:30 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Teleflex Incorporated (Amendment)

    SC 13G/A - TELEFLEX INC (0000096943) (Subject)

    2/14/24 10:04:36 AM ET
    $TFX
    Medical/Dental Instruments
    Health Care